BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
Apoptosis
,
Hepatitis
,
Liver
,
Hematopoietic cell
,
Fluoxetine
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
M II
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Charcot-Marie-Tooth disease
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Rapid screening for Chlamydia trachomatis infection by detecting α-mannosidase activity in urogenita…
Expression, purification and preliminary crystallographic analysis of Drosophila melanogaster lysoso…
Virtual screening and QSAR study of some pyrrolidine derivatives as α-mannosidase inhibitors for bin…
Heterodinuclear Mg(II)M(II) (M=Cr, Mn, Fe, Co, Ni, Cu and Zn) Complexes for the Ring Opening Copolym…
Synthesis of kifunensine thioanalogs and their inhibitory activities against HIV-RT and α-mannosidas…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)
The Use of Samsung Health and ECG M-Trace Base II Applications in the Secondary Prevention After Str…
Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-1…
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Imm…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ